Latest Financial Results News

Matsa Resources has commenced mining at its Devon Pit Gold Mine, backed by a robust feasibility study and a maiden reserve of 46,000 ounces. The company also sealed a $101 million option deal with AngloGold Ashanti for part of its Lake Carey project, while successfully fending off an unsolicited takeover bid.

Harvest Technology Group reported a 19% improvement in normalized EBITDA for Q3 FY25 alongside a $1.6 million capital raise, reinforcing its strategic plan to achieve profitability by FY27.

Terragen Holdings has launched its new probiotic products for ruminants, initiated multiple key trials including methane mitigation and crop yield studies, and secured a US patent allowance, positioning itself for global market expansion.

MPower Group has completed a pivotal equity conversion of its Narromine Renewable Energy Project, extinguishing $10.36 million in project funding and positioning itself for a $700,000 gain. The company also secured additional financing and advanced its renewable energy pipeline amid ongoing operational challenges.

SomnoMed Limited reported a robust 23.2% revenue increase in Q3 FY25, reaffirming its full-year guidance while actively addressing new US tariffs through potential duty-free exemptions.

Hydralyte North America reported a 16% rise in Q1 FY25 net sales and improved gross margins, supported by a strategic capital raise and upcoming product launches targeting brain and gut health.

GBM Resources Limited reports significant progress in its exploration programs and asset sales for Q1 2025, including a key Mt Morgan divestment and ongoing farm-in developments at Mt Coolon.

Cape Range Ltd’s Malaysian software arm Biztrak delivered robust 29% revenue growth in Q1 2025, driven by e-invoicing initiatives, even as a planned rights issue was cancelled due to shareholder withdrawal amid market volatility.

Eneco Refresh Limited reports solid 8% year-to-date revenue growth for Q3 FY2025, underpinned by gains in its water and plastics segments and improved cash flow.

Acrux Limited reports strong momentum from recent topical pharmaceutical launches, driving a significant uptick in profit share income expected in the coming quarter. The company also secured nearly $4 million through a placement and share purchase plan, alongside a $1.73 million R&D-backed loan.

Pacific Current Group reported a solid 3.2% increase in funds under management to A$31 billion for Q1 2025, driven primarily by strong inflows at its USD-denominated boutique Pennybacker and positive market revaluations.

MedAdvisor Solutions reported a challenging third quarter with steep revenue declines, driven by delayed program launches and US sales underperformance, but is executing a strategic overhaul and cost-cutting measures to position for a rebound and 15% revenue growth in FY26.